Sana Biotechnology (SANA) Treasury Shares (2020)

Sana Biotechnology has reported Treasury Shares for 7 years, with the latest figure at $5.1 million in Q1 2026.

• Quarterly Treasury Shares rose 14.66% year-over-year to $5.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.1 million (up 14.66% YoY) and the FY2025 annual result came in at $3.8 million, up 7.23% from the prior year.
• Treasury Shares rose to $5.1 million in Q1 2026 per SANA's latest filing, from $3.8 million in the prior quarter.
• Over five years, Treasury Shares peaked at $5.1 million in Q1 2026 and troughed at $806000.0 in Q3 2022.
• A 5-year average of $3.0 million and a median of $3.5 million in 2025 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2022 and 2024: Treasury Shares slumped 86.1% in 2022, then jumped 167.52% in 2024.
• Over 5 years, Treasury Shares stood at $885000.0 in 2022, then surged by 164.52% to $2.3 million in 2023, then soared by 52.5% to $3.6 million in 2024, then rose by 7.23% to $3.8 million in 2025, then jumped by 33.59% to $5.1 million in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $5.1 million, $3.8 million, and $3.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.